Attached files

file filename
EX-4.1 - FORM OF WARRANT AMENDMENT AGREEMENT - STRATA Skin Sciences, Inc.ex_4-1.htm

 
 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

_____________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): January 22, 2016


STRATA SKIN SCIENCES, INC.
(Exact Name of Registrant Specified in Charter)
 
 
 
Delaware
000-51481
13-3986004
(State or Other
(Commission File
(I.R.S. Employer
Jurisdiction of
Number)
Identification No.)
Incorporation)
 
 
 
 
 
100 Lakeside Drive, Suite 100, Horsham,
Pennsylvania
       19044
 
 
(Address of Principal Executive Offices)
(Zip Code)
 
 
 
Registrant's telephone number, including area code:   215-619-3200

N/A
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))    



Item 1.01 Entry into a Material Definitive Agreement
On January 22, 2016, the Company agreed to extend the expiration date of two outstanding Series B common stock warrants for six months.  The two warrants, exercisable for an aggregate of 4,995,321 shares of Common Stock of the Company at an exercise price of $0.75 per share, may be exercised by the respective holder at any time until July 24, 2016.
 
 
Item 9.01
 
Financial Statements and Exhibits
 
     
Exhibit No
 
Exhibit Description
 
4.1
 
Form of Warrant Amendment Agreement




- 2 -


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
STRATA SKIN SCIENCES, INC.
 
By:
/s/ Christina Allgeier
 
 
Christina Allgeier     
 
 
Chief Financial Officer
 

Date:  January 22, 2016


 
 





- 3 -